Press Release

In-vitro Diagnostics Market is Forecast To Rise at 4.5% CAGR; Launch Of Altostar Molecular Diagnostics Workflow By Altona Diagnostics Gmbh Will Support Growth

In-Vitro Diagnostics Market To Reach USD 87.11 Billion By 2026; Increasing Prevalence of Cancer Will Enable Growth

Introduction of new techniques for disease diagnosis is a key factor driving the global in-vitro diagnostics market, states Fortune Business Insights in a report, titled “In-vitro Diagnostics Market Size, Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019-2026.”

Browse Complete Report:

https://www.fortunebusinessinsights.com/industry-reports/in-vitro-diagnostics-ivd-market-101443

The Major Companies in The Global In-Vitro Diagnostics Market Include:

  • Hoffmann-La Roche Ltd
  • Abbott
  • Siemens
  • Thermo Fisher Scientific Inc.
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • QIAGEN
  • Sysmex Corporation
  • Quest Diagnostics Incorporated
  • Other Prominent Players

According to the report, the global in-vitro diagnostics market was valued at USD 61.22 Billion in 2018 is predicted to reach USD 87.11 Billion by 2026, exhibiting a CAGR of 4.5% during the forecast period.

As per the report published by Fortune Business Insights, the reagents and consumables segment is expected to hold maximum shares in the global-vitro diagnostics market during the forecast period owing to the increasing research and development activities for the diagnosis of chronic diseases. In addition, the escalating demand for self-test and point-of-care devices will subsequently increase the demand for reagents and consumables segment, which, will, in, turn boost the global in-vitro diagnostics market revenue during the forecast period.

The report offers an elaborative overview of the trends prevailing in the in-vitro diagnostics industry.  It also includes exclusive data which provides information about the in-vitro diagnostics market dynamics and competitive landscape. The report gives weightage to the segmentation in the global in-vitro diagnostics market and provides proficient facts and figures besides offering informative tools to assist companies in their overall business growth.

Get Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/in-vitro-diagnostics-ivd-market-101443

 “Increasing Prevalence of Chronic and Infectious Disease Will Enable Growth “

The launch of diagnostic and rapid testing tools by leading market players will propel growth of the global in-vitro diagnostics market. For instance, Thermo Fisher Scientific launched Phadia 200 for diagnosis of allergy & autoimmune conditions. The launch of Phadia 200 is anticipated to increase the revenue of the company. According to the report, the reagents and consumables segment will account for a major portion in the global in-vitro diagnostics market during the forecast period owing to the adoption of self- test and point-of-care devices. Furthermore, the instrument segment is likely to grow at a moderately slower pace during the forecast period. Rising technological advancement is predicted to aid growth of the segment. Moreover, the increasing cases of cancer and infectious disease around the world will further accelerate global in-vitro diagnostics market growth.

“Launch of Altostar Molecular Diagnostics Workflow Will Boost Growth”

Altona Diagnostics GmbH, molecular diagnostic testing solutions company launched a CE-IVD marked AltoStar Molecular Diagnostics Workflow. AltoStar Molecular Diagnostics a flexible and efficient automatic system that automates the entire workflow from sample preparation up to analysis. Fortune Business Insights states the launch of CE-IVD marked AltoStar Molecular Diagnostics Workflow is expected to boost the in-vitro diagnostics market revenue. Furthermore, the oncology segment is likely to grow at a considerable rate during the forecast period. Rising adoption and availability of advanced home care kits such as fecal occult blood test (FOBT) for diagnosis of colon cancer in homecare settings is one of the major factor likely to fuel demand for the oncology segment, which, will, in turn, uplift the global in-vitro diagnostics market shares

“Major Segmentation in The Global In-Vitro Diagnostics Market Report”

  • By Product Type Outlook/ Analysis
  • By Application Outlook/ Analysis
  • By Technique
  • By End User Outlook/ Analysis

Speak to Analyst:

https://www.fortunebusinessinsights.com/enquiry/check-discount/in-vitro-diagnostics-ivd-market-101443

KEY QUESTIONS ANSWERED:

  • What is the market size and growth rate of the global and regional market by various segments?
  • What is the market size and growth rate of the market for selective countries?
  • Which region or sub-segment is expected to drive the market in the forecast period?
  • What Factors are estimated to drive and restrain the market growth?
  • What are the key technological and market trends shaping the market?
  • What are the key opportunities in the market?
  • What are the key companies operating in the market?
  • Which company accounted for the highest market share?
  • Why Choose Fortune Business Insights?

View Related Report:

Blood Glucose Meters Market Share by Top Players to Worth USD 15.4 Billion by 2026 | Roche, Medtronic, Abbott, Sanofi and more

Immunoglobulins Market to Reach US$ 18,378.0 Mn by 2025 | Top Players Grifols, CSL Behring, Kedrion Biopharma

Botulinum Toxin Market Size | Top 10 Global Industry Share | CAGR of 8.0 % Forecast 2019 to 2026

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close